Latest news
Loading news…
Terrain Bio
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Massachusetts, United States Founded 2023 1-10 employees For Profit
Terrain BioSciences accelerates RNA-based therapeutics and vaccine development using AI and proprietary platforms.
Terrain Bio was acquired by Eclipse Bioinnovations in 2026.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 11
- Patents granted
- 0
- Trademarks
- 0
- IT spend
- $255K
Company Info
- Founded
- 2023
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 6
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Jan 26, 2026
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- 0.9
- Trend (30d)
- 1.2
- Trend (90d)
- 0.3
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Terrain Bio
Loading news…
FAQs about Terrain Bio
People who checked this page also checked these
Browse the full Acquirezy directory.